Central Sensitisation Syndrome in Women With Endometriosis
Studies how often central sensitisation syndrome occurs in women with endometriosis.
Plain-language title generated from the registry record
Registry title: Central Awareness in Women With Endometriosis
Key facts
- Where
- Bologna, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Source: NCT06773065, who can take part
Where in Italy
- IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Trial code
- NCT06773065
- Record updated
- 14 January 2025
- Original description
Gathering some information obtained during the gynaecological examination and transvaginal ultrasound check-up to be able to assess the prevalence of Central Sensitisation Syndrome (CSS) in women with endometriosis and also to be able to assess related risk factors. CSS has been defined as an algic syndrome due to a hyperactivation of the sensitivity circuit at a central level; the diagnosis is based on the result obtained from a questionnaire, the Central Sensitisation Inventory (CSI), which evaluates the presence and intensity of 25 clinical symptoms. For this reason, a questionnaire is proposed to be completed at the time of the check-up visit.Read full original descriptionShow less
The Role Of Central Sensitisation In Women With Endometriosis: A Prospective Observational Study
Gathering some information obtained during the gynaecological examination and transvaginal ultrasound check-up to be able to assess the prevalence of Central Sensitisation Syndrome (CSS) in women with endometriosis and also to be able to assess related risk factors. CSS has been defined as an algic syndrome due to a hyperactivation of the sensitivity circuit at a central level; the diagnosis is based on the result obtained from a questionnaire, the Central Sensitisation Inventory (CSI), which evaluates the presence and intensity of 25 clinical symptoms. For this reason, a questionnaire is proposed to be completed at the time of the check-up visit.
Inclusion: Women with a clinical, ultrasound and/or surgical diagnosis of endometriosis; Aged between 18 and 50 years; Patients starting or already taking hormone therapy; Patients coming for a first visit or outpatient follow-up visit; Signature of informed consent to participate in the study.
Exclusion: Patients with poor compliance with hormone therapy, who are not taking it properly or have discontinued therapy spontaneously; Positive history of any malignant neoplasm; Positive medical history of specific medical conditions that adversely affect the central nervous system, such as: brain or spinal cord damage, neurological diseases or peripheral nerve damage, multiple sclerosis; Post-menopausal women (spontaneous or iatrogenic); Virgo patients.